Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 2
1965 2
1967 2
1969 4
1970 3
1971 4
1972 7
1974 2
1975 7
1976 5
1977 6
1978 1
1979 3
1980 3
1981 1
1982 3
1984 3
1985 3
1986 5
1988 5
1989 3
1990 10
1991 4
1992 12
1993 6
1994 9
1995 12
1996 5
1997 8
1998 6
1999 6
2000 8
2001 4
2002 4
2003 9
2004 8
2005 6
2006 10
2007 8
2008 11
2009 6
2010 10
2011 10
2012 4
2013 9
2014 9
2015 8
2016 17
2017 11
2018 19
2019 15
2020 13
2021 12
2022 19
2023 33
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Wormser
Page 1
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Choudhary P, Kolassa R, Keuthage W, Kroeger J, Thivolet C, Evans M, Ré R, de Portu S, Vorrink L, Shin J, Habteab A, Castañeda J, da Silva J, Cohen O; ADAPT study Group. Choudhary P, et al. Lancet Diabetes Endocrinol. 2022 Oct;10(10):720-731. doi: 10.1016/S2213-8587(22)00212-1. Epub 2022 Sep 1. Lancet Diabetes Endocrinol. 2022. PMID: 36058207 Clinical Trial.
The dynamics of 11-beta-hydroxy-androstenedione (11 OHAD) metabolism in man.
Lejeune-Lenain C, Courtois P, Art G, Franckson JR. Lejeune-Lenain C, et al. J Endocrinol Invest. 1984 Dec;7(6):551-8. doi: 10.1007/BF03349485. J Endocrinol Invest. 1984. PMID: 6397500
The aim of the study was to determine the main metabolic parameters of 11-beta-hydroxy-androstenedione (11 OHAD) in man. Seven normal subjects were investigated at 1-3 months interval by 2 types of isotope dilution techniques using a tritiated tracer: constant infusion and …
The aim of the study was to determine the main metabolic parameters of 11-beta-hydroxy-androstenedione (11 OHAD) in man. Seven normal …
Improving the production of 9α-hydroxy-4-androstene-3,17-dione from phytosterols by 3-ketosteroid-Δ1-dehydrogenase deletions and multiple genetic modifications in Mycobacterium fortuitum.
Liu X, Zhang J, Yuan C, Du G, Han S, Shi J, Sun J, Zhang B. Liu X, et al. Microb Cell Fact. 2023 Mar 16;22(1):53. doi: 10.1186/s12934-023-02052-y. Microb Cell Fact. 2023. PMID: 36922830 Free PMC article.
However, in the process of phytosterol biotransformation to manufacture 9-OHAD, product degradation, and by-products restrict 9-OHAD output. ...Therefore, hsd4A and fadE28-29 were co-expressed in MFdeltakstDdeltaopccr successfully eliminating the two by-products. Co …
However, in the process of phytosterol biotransformation to manufacture 9-OHAD, product degradation, and by-products restrict 9-OH
Improving the biotransformation efficiency of soybean phytosterols in Mycolicibacterium neoaurum by the combined deletion of fbpC3 and embC in cell envelope synthesis.
Xiong LB, Liu HH, Song L, Dong MM, Ke J, Liu YJ, Liu K, Zhao M, Wang FQ, Wei DZ. Xiong LB, et al. Synth Syst Biotechnol. 2021 Dec 6;7(1):453-459. doi: 10.1016/j.synbio.2021.11.007. eCollection 2022 Mar. Synth Syst Biotechnol. 2021. PMID: 34938904 Free PMC article.
The deficiency of this gene raised the cell permeability, thereby enhancing the steroid uptake and utilization. The 9-OHAD yield in the fbpC3-deficient 9-OHAD-producing strain was increased by 21.3%. Moreover, the combined deletion of fbpC3 and embC further increase …
The deficiency of this gene raised the cell permeability, thereby enhancing the steroid uptake and utilization. The 9-OHAD yield in t …
Engineering phytosterol transport system in Mycobacterium sp. strain MS136 enhances production of 9α-hydroxy-4-androstene-3,17-dione.
He K, Sun H, Song H. He K, et al. Biotechnol Lett. 2018 Apr;40(4):673-678. doi: 10.1007/s10529-018-2520-9. Epub 2018 Feb 1. Biotechnol Lett. 2018. PMID: 29392454
RESULTS: 9-OHAD can be produced via the controlled degradation of phytosterols by mycobacteria. ...The resultant of the Mycobacterium sp. strain MS136-GAB gave 5.7 g 9-OHAD l(-1), which was a 20% increase over 4.7 g l(-1) by the wild-type strain. ...
RESULTS: 9-OHAD can be produced via the controlled degradation of phytosterols by mycobacteria. ...The resultant of the Mycobacterium …
From choice architecture to choice engineering.
Dan O, Loewenstein Y. Dan O, et al. Nat Commun. 2019 Jun 26;10(1):2808. doi: 10.1038/s41467-019-10825-6. Nat Commun. 2019. PMID: 31243285 Free PMC article.
Role Identification and Application of SigD in the Transformation of Soybean Phytosterol to 9α-Hydroxy-4-androstene-3,17-dione in Mycobacterium neoaurum.
Xiong LB, Liu HH, Xu LQ, Wei DZ, Wang FQ. Xiong LB, et al. J Agric Food Chem. 2017 Jan 25;65(3):626-631. doi: 10.1021/acs.jafc.6b05314. Epub 2017 Jan 12. J Agric Food Chem. 2017. PMID: 28035826
9alpha-Hydroxy-4-androstene-3,17-dione (9-OHAD) is a valuable steroid pharmaceutical intermediate which can be produced by the conversion of soybean phytosterols in mycobacteria. ...Here, a sigma factor D (sigD) was investigated due to its dramatic downregulation during th …
9alpha-Hydroxy-4-androstene-3,17-dione (9-OHAD) is a valuable steroid pharmaceutical intermediate which can be produced by the conver …
406 results